EQT strikes €10.8bn deal to take Qiagen private at 40.3% premium

Qiagen is a Dutch life science tools and diagnostics company listed in Frankfurt and New York.

22 October 2026•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.